What does this research mean for the field?

Mitigating the dose- and duration-dependent toxicities of long-term glucocorticoid therapy in rheumatic diseases requires baseline assessments, continuous monitoring, integration of steroid-sparing agents, and prompt specialist referral. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

To review common adverse events linked to glucocorticoid use in rheumatic diseases and outline strategies for baseline assessment, toxicity prevention, and specialist management.

August 22, 2026Expert Opinion on Drug Safety

Early recognition, prevention, and management of glucocorticoid toxicity in patients with rheumatic diseases

View Full Paper

Ask AI

Bookmark

Authors

LCLouis Cohen VTVivekanand Tiwari JTJohn Tesser

Discussion

Member takes

Overview

Review highlights dose-dependent glucocorticoid toxicities in rheumatic diseases, indicating steroid-sparing therapies and early referral reduce long-term harm.

Key Points

To review common adverse events linked to glucocorticoid use in rheumatic diseases and outline strategies for baseline assessment, toxicity prevention, and specialist management.
Reviewed clinical evidence and management guidelines regarding glucocorticoid-related toxicity in conditions including rheumatoid arthritis, polymyalgia rheumatica, and vasculitis.
Evaluated differences in glucocorticoid prescribing and referral practices between primary care physicians and rheumatology specialists.
Prolonged glucocorticoid therapy causes dose- and duration-dependent adverse events, including osteoporosis, fractures, hyperglycemia, infection, cardiovascular events, weight gain, and psychiatric disturbances.
Implementation of baseline screening, continuous clinical monitoring, and timely introduction of steroid-sparing agents mitigates long-term drug toxicity.
Early referral pathways and enhanced communication between primary care physicians and specialists reduce prolonged steroid exposure and prevent irreversible tissue damage.

Cite This Study

Cohen et al. (2026) studied this question.

synapsesocial.com/papers/6a895eaeca7ade938187cc0a https://doi.org/10.1080/14740338.2026.2718746

View Full Paper

Ask AI

Bookmark

August 22, 2026Expert Opinion on Drug Safety

Early recognition, prevention, and management of glucocorticoid toxicity in patients with rheumatic diseases

View Full Paper

Ask AI

Bookmark

Authors

LCLouis Cohen VTVivekanand Tiwari JTJohn Tesser

Discussion

Member takes

Overview

Review highlights dose-dependent glucocorticoid toxicities in rheumatic diseases, indicating steroid-sparing therapies and early referral reduce long-term harm.

Key Points

To review common adverse events linked to glucocorticoid use in rheumatic diseases and outline strategies for baseline assessment, toxicity prevention, and specialist management.
Reviewed clinical evidence and management guidelines regarding glucocorticoid-related toxicity in conditions including rheumatoid arthritis, polymyalgia rheumatica, and vasculitis.
Evaluated differences in glucocorticoid prescribing and referral practices between primary care physicians and rheumatology specialists.
Prolonged glucocorticoid therapy causes dose- and duration-dependent adverse events, including osteoporosis, fractures, hyperglycemia, infection, cardiovascular events, weight gain, and psychiatric disturbances.
Implementation of baseline screening, continuous clinical monitoring, and timely introduction of steroid-sparing agents mitigates long-term drug toxicity.
Early referral pathways and enhanced communication between primary care physicians and specialists reduce prolonged steroid exposure and prevent irreversible tissue damage.

Cite This Study

Cohen et al. (2026) studied this question.

synapsesocial.com/papers/6a895eaeca7ade938187cc0a https://doi.org/10.1080/14740338.2026.2718746

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark